HJHrishikesh Bhaskar Joshi

Hrishikesh Bhaskar Joshi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hrishikesh Bhaskar Joshi has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • A.G. Timoney

    Bristol Urological Institute, Bristol, United Kingdom

    7 shared publications
  • F.X. Keeley

    Bristol Urological Institute, Bristol, United Kingdom

    7 shared publications
  • A. Stainthorpe

    From the Bristol Urological Institute, Southmead Hospital, Bristol, and Taunton and Somerset National Health Service Trust, Taunton, United Kingdom

    5 shared publications
  • Aditya Raja

    Department of Urology, Cardiff and Vale University Health Board, Cardiff, UK

    5 shared publications
  • Francis X. Keeley

    Bristol Urological Institute, Southmead Hospital, University of Bristol, Bristol, United Kingdom

    4 shared publications
  • Anthony G. Timoney

    Bristol Urological Institute, Bristol, United Kingdom

    3 shared publications

Latest Publications

  • The Impact of Early COVID-19 Pandemic on the Presentation and Management of Urinary Calculi Across the Globe: A Systematic Review

    by Natesh Shivakumar, Dhanya Nantha Kumar, Hrishi Joshi

    Introduction: It is acknowledged that the COVID-19 pandemic has had a major impact on health care services around the globe with possible worse outcomes. It has resulted in stretch of resources with canceled or delayed procedures. Patients with urinary calculi have also suffered the negative impact. This systematic review aims to assess the impact of the early COVID-19 pandemic on the presentation and management of urinary calculi around the globe. Methods: We reviewed the impact of early COVID-19 on the clinically important aspects of stone disease using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. We searched Medline, Embase, and Central databases using themes of COVID-19 OR Sars-Cov-2 OR pandemic OR coronavirus AND kidney stone, urinary calculi, urolithiasis, and similar allied terms. Inclusion criteria were studies with data on both pre- and COVID-19 period covering one or more of eight clinical domains. Results: Our search returned 231 studies, after removal of duplicates, of which 18 studies were included for analysis. The number of patients presenting to hospital declined by 21%–70% at the beginning of the pandemic, whereas majority of studies reported increased associated complications. There are mixed reports in terms of delay to presentation and use of conservative management. There was a consistent trend toward reduction in elective procedures with wide variations (shockwave lithotripsy 38%–98%, percutaneous nephrolithotomy 94%–100%, and ureteroscopy 8%–98%). There was a trend toward increased nephrostomy insertion with the onset of the pandemic. Conclusion: This review demonstrated the differences in the number of patients presenting to hospital, complication rates, and management of urinary calculi, including surgical interventions, with the onset of the COVID-19 pandemic. It offers baseline global information that would help understand the impact of early pandemic, variations in practices, and be useful for future comparisons.


  • An evaluation of the pharmacotherapeutic options for the treatment of adult phimosis. A systematic review of the evidence

    by Anna Lygas, Hrishikesh Bhaskar Joshi

    Topical pharmacotherapy is often practiced in the treatment of adults with phimosis or Lichen Sclerosus (LS). However, it is unclear if it is effective. The authors review pharmacological treatments in adults with phimosis or LS using the Preferred Reporting of Items for Systematic Reviews and Meta- analysis (PRISMA) methodology. They searched seven databases using key words phimosis, drug treatment, medical, treatment, lichen sclerosis, pharmacological treatment, medications, comparison study for all English language articles from 1962-2021. Inclusion criteria were patients >18 yr., and the use of topical medical treatment with outcome data. The article includes the authors’ expert opinion and their perspectives for the future. There is limited research, with significant heterogeneity, which suggests the probable safety of topical steroids with some potential to reduce the signs and symptoms of LS. However, good quality research, with patient reported outcome data, is required to establish its true role and effectiveness.


  • Open Access

    Ureteric stents: Overview of current clinical applications and economic implications

    by Gaurav Mohan Sali, Hrishikesh B Joshi

    Ureteric stents are one of the most crucial tools used for various clinical conditions in the urological field. Placement of a ureteric stent, for short‐ or long‐term use, remains one of the commonest urological interventional procedures. In the past few decades, ureteral stents have undergone notable technological advancements. However, an ideal stent without significant side‐effects is yet to be engineered. Indwelling ureteric stents are often accompanied by physical distress to the patient and clinical complications, such as bacterial adhesion, encrustation, malpositioning, stent fracture and forgotten stent syndrome, that influence patients’ health‐related quality of life. In the market, different stent types are available, designed to reduce infections, and improve patient symptoms and tolerance. In this review, we have emphasized the recent developments that have taken place in stent design, size, materials and coating. This overview looks at current practices and problems related to stents, along with clinical and economic considerations. Few trial studies have been enumerated in the context of utilization of a ureteral stent symptom questionnaire and various stent models to compare their effects in patients.


  • Open Access

    The impact of urinary stone disease and their treatment on patients’ quality of life: a qualitative study

    by Aditya Raja, Fiona Wood, Hrishi B. Joshi

    Urinary stone disease is a common, often recurrent disease, that can have a negative impact on patients’ health-related quality of life (HRQoL), often effecting working, productive members of society. The literature lacks data from structured, qualitative research which could give unique insight into patients’ HRQoL. The objective is to understand the impact of urinary stone disease and treatments on patients’ HRQoL, from patients’ and their relatives’ perspective using qualitative and quantitative methodologies. Semi-structured interviews and a focus group were used to understand the HRQoL issues of patients with urinary stones disease, covering the American Urology Association index stone categories. Thematic analysis was performed (using qualitative data analysis software). Familial impact was assessed using the family-related outcome measure (FROM-16©). 62 patients with stone disease and interventions (mean age 51, range 19–92) participated. Data collection stopped when data saturation was achieved. Analysis revealed negative impact of stone disease and interventions on the patients’ HRQoL, affecting domains of pain, physical symptoms, outlook on life, work/career, change in lifestyle/diet, social life, difficulties of daily living, travel/holiday problems, relationships and family member impact (106 themes grouped under ten broad headings). Sub-group analyses revealed similar impact in either sex, ureteric and renal stone groups. Recurrent stones were associated with work/financial concerns and treatment preferences varied accordingly. Our qualitative study presents detailed insights into the multidimensional impact of urinary calculi and their treatments on various domains of the HRQoL, confirming previous findings and adding new observations. The findings are expected to help in the development of patient-centric measures and communication tools.


  • Open Access

    Linguistic and cultural validation of Ureteral Stent Symptom Questionnaire in Hindi

    by Pushpendra Baghel, R. D. Sahu, Goto Gangkok, H. B. Joshi, Vinay Tomar, S. S. Yadav

    Introduction: In the year 2003, Joshi et al . developed a validated outcome assessment tool to measure the ureteral stent-related symptoms. The original English language Ureteral Stent Symptom Questionnaire (USSQ) has been validated in various languages worldwide. Our objective was to develop the USSQ in Hindi, a commonlyused language in India, by validating it in patients undergoing ureteroscopic lithotripsy. Materials and Methods: A final Hindi version of the USSQ was derived from the original English version to apply to the study population by translation, back translation, and face-to-face interviews. The Hindi and English versions were completed by 70 patients undergoing ureteroscopic lithotripsy with stent in situ , on postoperative days 7 and 8, and 4 weeks after stent removal. Similarly, discriminant validity was checked among 50 healthy individuals. A detailed statistical analysis was used to correlate results (Cronbach's α coefficient, Spearman's correlation, and Mann–Whitney U-test). Results: A total of 70 patients were enrolled in the study and 61 completed the final assessment. The median age was 35 years (range: 18–60 years). The USSQ domain scores with the stent in situ were higher than poststent status. The test–retest reliability checked by Cronbach's α coefficient (>0.44) and Spearman's correlation coefficient (>0.44) were acceptable to good. We found high discriminant validity of the questionnaire between patients with stent and the healthy controls ( P < 0.05). Conclusion: Our results demonstrate satisfactory validity for the Hindi version of the USSQ for the assessment of quality of life in patients with stent. This is ready for application in the clinical studies and the future stent-related research in Hindi language.


  • Fournier's gangrene: diagnosis and management aided by repeated clinical examination and ultrasound

    by Jayan George, Aditya Raja, David Chun Hei Li, Hrishi Joshi

    We describe a case of a man aged 57 years admitted to our tertiary centre via his general practitioner, presenting with a 1-week history of scrotal pain, testicular swelling and fluctuance. He was initially managed in the community with flucoclaxacillin for 1 week, but failed to respond to treatment. Clinical history was suggestive of Fournier's gangrene, but initial examination was not conclusive. Repeated examination over the next hour aided diagnosis and helped to track the progression of the condition. The patient was treated with intravenous antibiotics and prepared for theatre. Since there was a delay in getting the patient to theatre, an ultrasound scan was performed to help ascertain the extent of the disease to aid surgical planning. Following successful debridement and skeletalisation of the testicles and ward recovery, he was transferred for plastic reconstruction.


  • Tight foreskin

    by Aditya Raja, Ian Perry, Hrishi B Joshi

    #### What you need to know A 25 year old man says that his foreskin has been tight for several months. It will not pull back. He is starting to have painful erections and difficulty having sex. At age 3 years, 90% of boys have a fully retractile foreskin; this rises to 95% of 16-17 year olds.1 2 Phimosis is a common condition in which a band in the foreskin prevents retraction over the glans. Phimosis may persist from childhood or be acquired, often through a process that has resulted in scarring. Asymptomatic phimosis needs no treatment. Patients with symptomatic phimosis may complain of a tight foreskin, difficulty cleaning the glans, and sexual problems such as splitting of the skin and painful erections (fig 1⇓). Rarely, phimosis may present with difficulty passing urine, associated with ballooning of the foreskin. Fig 1 Splits in the foreskin of a 24 year old’s penis …


  • The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ)

    by Dominik Abt, Kristina Dötzer, Patrick Honek, Karolina Müller, Daniel Stephan Engeler, Maximilian Burger, Hans-Peter Schmid, Thomas Knoll, Francesco Sanguedolce, Hrishi B. Joshi, et al.

    We developed and validated the German version of the Ureteral Stent Symptoms Questionnaire (USSQ) for male and female patients with indwelling ureteral stents.


  • Evidence of Nonuniformity in Urothelium Barrier Function between the Upper Urinary Tract and Bladder

    by Nicholas A. Williams, Luke Barnard, Chris J. Allender, Jenna L. Bowen, Mark Gumbleton, Tim Harrah, Aditya Raja, Hrishi B. Joshi

    We compared the relative permeability of upper urinary tract and bladder urothelium to mitomycin C. Ex vivo porcine bladder, ureters and kidneys were dissected out and filled with 1 mg ml(-1) mitomycin C. At 60 minutes the organs were emptied and excised tissue samples were sectioned parallel to the urothelium. Sectioned tissue was homogenized and extracted mitomycin C was quantified. Transurothelial permeation across the different urothelia was calculated by normalizing the total amount of drug extracted to the surface area of the tissue sample. Average mitomycin C concentrations at different tissue depths (concentration-depth profiles) were calculated by dividing the total amount of drug recovered by the total weight of tissue. Mitomycin C permeation across the ureteral urothelium was significantly greater than across the bladder and renal pelvis urothelium (9.07 vs 0.94 and 3.61 μg cm(-2), respectively). Concentrations of mitomycin C in the ureter and kidney were markedly higher than those achieved in the bladder at all tissue depths. Average urothelial mitomycin C concentrations were greater than 6.5-fold higher in the ureter and renal pelvis than in the bladder. To our knowledge we report for the first time that the upper urinary tract and bladder show differing permeability to a single drug. Ex vivo porcine ureter is significantly more permeable to mitomycin C than bladder urothelium and consequently higher mitomycin C tissue concentrations can be achieved after topical application. Data in this study correlate with the theory that mammalian upper tract urothelium represents a different cell lineage than that of the bladder and it is innately more permeable to mitomycin C.